These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 36257382

  • 1. The advances of calcium oxalate calculi associated drugs and targets.
    Lai Y, Zheng H, Sun X, Lin J, Li Q, Huang H, Hou Y, Zhong H, Zhang D, Fucai T, He Z.
    Eur J Pharmacol; 2022 Nov 15; 935():175324. PubMed ID: 36257382
    [Abstract] [Full Text] [Related]

  • 2. [Molecular mechanism of renal stone formation].
    Hamamoto S, Taguchi K, Fujii Y.
    Clin Calcium; 2011 Oct 15; 21(10):1481-7. PubMed ID: 21960233
    [Abstract] [Full Text] [Related]

  • 3. Mechanism and influencing factors of crystal-cell interaction in the formation of calcium oxalate stones.
    Deng Z, Tan J, Zhang R, Zeng J, Yin G, Jiang X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May 28; 47(5):555-561. PubMed ID: 35753725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
    De Bellis R, Piacentini MP, Meli MA, Mattioli M, Menotta M, Mari M, Valentini L, Palomba L, Desideri D, Chiarantini L.
    PLoS One; 2019 May 28; 14(6):e0218734. PubMed ID: 31238335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal tubular damage/dysfunction: key to the formation of kidney stones.
    Khan SR.
    Urol Res; 2006 Apr 28; 34(2):86-91. PubMed ID: 16404622
    [Abstract] [Full Text] [Related]

  • 10. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
    White DJ, Nancollas GH.
    Calcif Tissue Int; 1987 Feb 28; 40(2):79-84. PubMed ID: 3105837
    [Abstract] [Full Text] [Related]

  • 11. Gastrin-releasing peptide receptor gene silencing inhibits the development of the epithelial-mesenchymal transition and formation of a calcium oxalate crystal in renal tubular epithelial cells in mice with kidney stones via the PI3K/Akt signaling pathway.
    Wang XF, Zhang BH, Lu XQ, Wang RQ.
    J Cell Physiol; 2019 Feb 28; 234(2):1567-1577. PubMed ID: 30144073
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar 28; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 19. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B.
    Ther Umsch; 2003 Feb 28; 60(2):79-87. PubMed ID: 12649986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.